Crescent Biopharma (CBIO) Institutional Ownership $13.75 -0.04 (-0.29%) As of 02:39 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesOwnershipSEC FilingsSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)CurrentInstitutional OwnershipPercentage75.19%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$61.78MNumber ofInstitutional Sellers(last 12 months)0 Get CBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CBIO Institutional Buying and Selling by Quarter Crescent Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046% 8/15/2025 Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321% 8/15/2025 Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321% 8/15/2025 Braidwell LP261,504$4.22M0.1%N/A1.338% 8/15/2025 BVF Inc. IL1,387,863$22.40M0.8%N/A7.099% 8/15/2025 Bank of America Corp DE9,231$149K0.0%N/A0.047% 8/15/2025 Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516% 8/14/2025 Commodore Capital LP453,686$7.32M0.5%N/A2.321% 8/13/2025 Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432% 8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139% Get the Latest News and Ratings for CBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crescent Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/7/2023 Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381% 2/15/2023 Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392% 11/10/2022 Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116% 11/7/2022 Virtu Financial LLC189,175$95K0.0%+250.5%0.601% 8/15/2022 Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755% 8/13/2022 Virtu Financial LLC53,977$96K0.0%N/A0.171% 2/10/2022 Acadian Asset Management LLC232,400$211K0.0%N/A0.740% 2/8/2022Raymond James & Associates32,800$30K0.0%-74.7%0.104% 2/1/2022 Assenagon Asset Management S.A.512,643$469K0.0%N/A1.632% 11/16/2021 Squarepoint Ops LLC25,527$105K0.0%-45.8%0.081% 11/16/2021 Two Sigma Advisers LP107,000$440K0.0%-30.0%0.341% 11/16/2021 Millennium Management LLC671,224$2.76M0.0%-14.8%2.140% 11/15/2021 Pura Vida Investments LLC372,582$1.53M0.0%N/A1.188% 11/15/2021 Dimensional Fund Advisors LP801,440$3.29M0.0%-13.4%2.555% 11/15/2021 GSA Capital Partners LLP175,751$722K0.1%+3.7%0.560% 11/12/2021 Johnson & Johnson66,951$275K0.0%N/A0.213% 11/12/2021 Parkman Healthcare Partners LLC133,449$548K0.1%-66.1%0.425% 11/12/2021 Stonepine Capital Management LLC2,635,014$10.83M4.9%-14.3%8.401% 11/12/2021 Geode Capital Management LLC351,541$1.44M0.0%+5.7%1.121% 11/10/2021 Goldman Sachs Group Inc.160,701$660K0.0%-38.4%0.512% 11/9/2021BlackRock Inc.270,718$1.11M0.0%-4.3%0.863% 11/2/2021Raymond James & Associates129,553$532K0.0%-4.1%0.413% 11/1/2021 Cherry Creek Investment Advisors Inc.20,000$82K0.1%N/A0.064% 10/29/2021 Commonwealth Equity Services LLC10,000$41K0.0%N/A0.032% 9/3/2021Parametric Portfolio Associates LLC21,019$91K0.0%-51.9%0.067% 8/19/2021 M Holdings Securities Inc.85,202$369K0.0%-9.6%0.272% 8/17/2021 Millennium Management LLC787,748$3.41M0.0%+46.1%2.511% 8/17/2021 22NW LP1,429,242$6.19M1.7%+84.4%4.557% 8/17/2021 Acuta Capital Partners LLC685,000$2.97M1.2%-27.1%2.184% 8/16/2021 Squarepoint Ops LLC47,060$204K0.0%-32.6%0.150% Cover all your expenses with just $118,000 invested? (Ad)Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just discovered a new way to do it with 10X less money.Start collecting this income (next payout coming soon)8/16/2021 PDT Partners LLC11,794$51K0.0%-78.6%0.038% 8/16/2021 Nantahala Capital Management LLC2,531,360$10.96M0.3%-1.2%8.070% 8/16/2021 Schonfeld Strategic Advisors LLC94,800$411K0.0%+11.0%0.302% 8/16/2021 Charles Schwab Investment Management Inc.13,113$57K0.0%-83.3%0.042% 8/16/2021 State Street Corp43,399$188K0.0%-88.5%0.138% 8/16/2021Tibra Equities Europe Ltd79,200$343K0.1%N/A0.253% 8/16/2021 Tocqueville Asset Management L.P.54,580$236K0.0%+37.9%0.174% 8/13/2021 Renaissance Technologies LLC448,197$1.94M0.0%N/A1.429% 8/13/2021 Northern Trust Corp106,943$463K0.0%-68.2%0.341% 8/13/2021 Geode Capital Management LLC332,479$1.44M0.0%-37.8%1.060% 8/13/2021 Vanguard Group Inc.1,422,331$6.16M0.0%-7.2%4.535% 8/12/2021 Trexquant Investment LP32,220$140K0.0%N/A0.103% 8/12/2021 XTX Topco Ltd15,265$66K0.0%N/A0.049% 8/12/2021 Dimensional Fund Advisors LP925,706$4.01M0.0%+2.0%2.951% 8/12/2021Advisory Services Network LLC19,700$85K0.0%N/A0.063% 8/12/2021 Stephens Inc. AR16,885$73K0.0%+64.6%0.054% 8/12/2021 JPMorgan Chase & Co.84,996$368K0.0%-33.1%0.271% 8/12/2021 Bank of Montreal Can212,398$971K0.0%+36.5%0.677% 8/12/2021Ergoteles LLC108,500$470K0.0%N/A0.346% 8/11/2021 Bank of New York Mellon Corp75,309$326K0.0%-44.8%0.240% 8/11/2021Quantitative Systematic Strategies LLC16,277$70K0.0%-45.7%0.052% 8/11/2021 Deutsche Bank AG194,933$844K0.0%-26.5%0.622% 8/5/2021 GSA Capital Partners LLP169,535$734K0.1%+553.8%0.541% 5/18/2021 Cubist Systematic Strategies LLC27,380$138K0.0%N/A0.087% (Data available from 1/1/2016 forward) CBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CBIO shares? During the previous two years, 10 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($22.40M), Frazier Life Sciences Management L.P. ($7.32M), Perceptive Advisors LLC ($7.32M), Commodore Capital LP ($7.32M), Soleus Capital Management L.P. ($6.46M), Affinity Asset Advisors LLC ($4.52M), and Braidwell LP ($4.22M).Learn more on Crescent Biopharma's institutional investors. What percentage of Crescent Biopharma's stock is owned by institutional investors? 75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings. Which institutional investors have been buying Crescent Biopharma's stock? Of the 10 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($1.39M), Commodore Capital LP ($453.69K), Perceptive Advisors LLC ($453.69K), Frazier Life Sciences Management L.P. ($453.69K), Soleus Capital Management L.P. ($400K), Affinity Asset Advisors LLC ($280.03K), and Braidwell LP ($261.50K). How much institutional buying is happening at Crescent Biopharma? Institutional investors have bought a total of 3,827,694 shares in the last 24 months. This purchase volume represents approximately $61.78M in transactions. Related Companies Geron Institutional Ownership Zenas BioPharma Institutional Ownership Rigel Pharmaceuticals Institutional Ownership Myriad Genetics Institutional Ownership Emergent Biosolutions Institutional Ownership Verastem Institutional Ownership Lexicon Pharmaceuticals Institutional Ownership XOMA Royalty Institutional Ownership Vanda Pharmaceuticals Institutional Ownership Codexis Institutional Ownership This page (NASDAQ:CBIO) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access